glp-1 receptor structure Glp 1 Stock Vector Images GLP-1 receptor agonist 7 |
Description
The therapeutic potential of GLP-1R and its agonists has reshaped approaches to managing type 2 diabetes mellitus (T2DM), cardiovascular diseases, obesity, and even neurodegenerative conditions
Hydration becomes critical on tirzepatide
In the Phase I/II KRYSTAL-1 study, Krazati plus cetuximab elicited a confirmed overall response rate of 34%, all of which were partial responses, meeting the primary endpoint, according to BMS
AP: Writing review & editing
The other authors have no conflicts of interest to disclose
